Morningstar1 个月
Capsida Biotherapeutics to Present New Preclinical Data for Potential Best-in-Class ...
NHP data demonstrate potential for CAP-004 to treat CNS, cardiac, and sensory manifestations of Friedreich's ataxia THOUSAND OAKS, Calif., Nov. 12, 2024 /PRNewswire/ -- Capsida Biotherapeutics ...